Global Non-Hodgkin’s Lymphoma Therapeutics Market Set to Reach US$ 18.6 Bn by 2034 Amid Rising Cancer Burden
The global Non-Hodgkin’s Lymphoma (NHL) Therapeutics Market is entering a high-growth phase driven by rising cancer incidence, rapid advancements in immunotherapy, and extensive drug development pipelines. Valued at US$ 8.0 billion in 2023, the market is projected to reach US$ 18.6 billion by 2034, expanding at a robust CAGR of 8.0% from 2024 to 2034. With a growing elderly population and...
0 Commenti 0 condivisioni 95 Views 0 Anteprima
flexartsocial.com https://www.flexartsocial.com